Biologic drugs (e.g. anti-tumor necrosis factors) are effective treatments for multiple chronic inflammatory diseases including rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis. Administration of biologic drugs is usually via subcutaneous self-injection, which provides many patient benefits compared to infusions including increased flexibility, reduced costs, and reduced caregiver burden. However, it is also associated with challenges such as needle phobia, patient treatment misconceptions and incorrect drug administration, and can be impacted by dexterity problems. Evidence suggests these problems, along with other drug administration challenges (e.g. patient forgetfulness, busy lifestyles, and polypharmacy), can redu...
Objective. To assess the extent to which ANSWER-2, an interactive online patient decision aid, redu...
International audienceThe world of injectable products is in good health with one-digit growth in Eu...
Winfried Demary,1 Holger Schwenke,2 Karin Rockwitz,3 Peter Kästner,4 Anke Liebhaber,5 Ulrich Sc...
Biologic drugs (e.g. anti-tumor necrosis factors) are effective treatments for multiple chronic infl...
PurposeDespite American College of Rheumatology recommendations, appropriate and timely initiation o...
Florence Schwarzenbach,1 Michèle Dao Trong,1 Laurent Grange,2 Philippe E Laurent,3 Herve Abry...
Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt the pr...
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and progres...
Rheumatoid arthritis (RA) is a progressive autoimmune inflammatory disorder characterized by cellula...
Background: Anti-tumor necrosis factor (anti-TNF) adherence is suboptimal. ava®, a reusable electrom...
Objective: To assess usability, bioavailability, and safety of subcutaneous self-administration of 0...
International audienceINTRODUCTION:The objective of the study was to compare compliance and acceptab...
Background: Multiple sclerosis (MS) currently requires long-term treatment with disease-modifying dr...
Pens and autoinjectors are mainly used for the subcutaneous delivery of biopharmaceuticals, primaril...
Biologic drugs, such as the anti-tumor necrosis factor (anti-TNF) antibody adalimumab, have represen...
Objective. To assess the extent to which ANSWER-2, an interactive online patient decision aid, redu...
International audienceThe world of injectable products is in good health with one-digit growth in Eu...
Winfried Demary,1 Holger Schwenke,2 Karin Rockwitz,3 Peter Kästner,4 Anke Liebhaber,5 Ulrich Sc...
Biologic drugs (e.g. anti-tumor necrosis factors) are effective treatments for multiple chronic infl...
PurposeDespite American College of Rheumatology recommendations, appropriate and timely initiation o...
Florence Schwarzenbach,1 Michèle Dao Trong,1 Laurent Grange,2 Philippe E Laurent,3 Herve Abry...
Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt the pr...
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and progres...
Rheumatoid arthritis (RA) is a progressive autoimmune inflammatory disorder characterized by cellula...
Background: Anti-tumor necrosis factor (anti-TNF) adherence is suboptimal. ava®, a reusable electrom...
Objective: To assess usability, bioavailability, and safety of subcutaneous self-administration of 0...
International audienceINTRODUCTION:The objective of the study was to compare compliance and acceptab...
Background: Multiple sclerosis (MS) currently requires long-term treatment with disease-modifying dr...
Pens and autoinjectors are mainly used for the subcutaneous delivery of biopharmaceuticals, primaril...
Biologic drugs, such as the anti-tumor necrosis factor (anti-TNF) antibody adalimumab, have represen...
Objective. To assess the extent to which ANSWER-2, an interactive online patient decision aid, redu...
International audienceThe world of injectable products is in good health with one-digit growth in Eu...
Winfried Demary,1 Holger Schwenke,2 Karin Rockwitz,3 Peter Kästner,4 Anke Liebhaber,5 Ulrich Sc...